InspireMD, Inc. (NSPR)

Market Cap	80.97M -2.9%
Revenue (ttm)	8.98M +28.1%
Net Income	-48.79M
EPS	-0.76
Shares Out	46.80M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,543
Open	1.750
Previous Close	1.770
Day's Range	1.700 - 1.820
52-Week Range	1.510 - 2.932
Beta	0.93
Analysts	Buy
Price Target	4.00 (+131.21%)
Earnings Date	Mar 18, 2026

About NSPR

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products to treat carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization. CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neurop...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 66
• Stock Exchange: NASDAQ
• Ticker Symbol: NSPR
• Website: https://www.inspiremd.com

Financial Performance

In 2025, InspireMD's revenue was $8.98 million, an increase of 28.11% compared to the previous year's $7.01 million. Losses were -$48.79 million, 52.4% more than in 2024.

Analyst Summary

According to one analyst, the rating for NSPR stock is "Buy" and the 12-month stock price target is $4.0.

Price Target

$4.0

(131.21% upside)

Analyst Consensus: Buy